ID   LM-MEL-5a
AC   CVCL_UC20
SY   LM-Mel-5a; LM-MEL-5; Ludwig Melbourne-MELanoma-5a
DR   ArrayExpress; E-MTAB-1496
DR   cancercelllines; CVCL_UC20
DR   GEO; GSM2371745
DR   Wikidata; Q95982554
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*02:01,03:01; B*07:02,57:01; C*06:02,07:02 (PubMed=23527996).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23527996).
CC   Omics: miRNA expression profiling.
CC   Omics: Transcriptome analysis by microarray.
CC   Miscellaneous: Age of donor, metastatic site and STR profile from personal communication of Cardwell T., Olivia Newton-John Cancer Research Institute.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D21S11: 29,30
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
RX   PubMed=23527996; DOI=10.1111/pcmr.12097;
RA   Behren A., Anaka M., Lo P.-H., Vella L.J., Davis I.D., Catimel J.,
RA   Cardwell T., Gedye C., Hudson C., Stan R., Cebon J.S.;
RT   "The Ludwig Institute for Cancer Research Melbourne melanoma cell line
RT   panel.";
RL   Pigment Cell Melanoma Res. 26:597-600(2013).
//
RX   PubMed=27852308; DOI=10.1186/s12943-016-0554-y;
RA   Andrews M.C., Cursons J., Hurley D.G., Anaka M., Cebon J.S.,
RA   Behren A., Crampin E.J.;
RT   "Systems analysis identifies miR-29b regulation of invasiveness in
RT   melanoma.";
RL   Mol. Cancer 15:72.1-72.20(2016).
//